Deregulation of apoptosis in colorectal carcinoma: Theoretical and therapeutic implications

Australian and New Zealand Journal of Surgery

Volumn 69, Issue 2, 1999, Pages 88-94

  Butler, Lisa M ^a   Hewett, Peter J ^a   Fitridge, Robert A ^a,b   Cowled, Prudence A ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Apoptosis; Bcl 2; Colorectal carcinoma; p53; Programmed cell death; Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL)

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; CANCER CELL; CANCER DIAGNOSIS; CELL PROLIFERATION; COLORECTAL CANCER; CYTOTOXICITY; DNA DAMAGE; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; REVIEW; TARGET CELL;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; COLON; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DNA NUCLEOTIDYLEXOTRANSFERASE; HUMANS; IN SITU NICK-END LABELING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032910650     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1622.1999.01498.x     Document Type: Review

References (98)

1. National Cancer Prevention Policy 1993. Sydney: The Australian Cancer Society, 1993.
2. South Australian Cancer Registry. Epidemiology of Cancer in South Australia. Incidence, Mortality and Survival 1977-96. Incidence and Mortality 1996. Adelaide: Public and Environmental Health Service, South Australian Health Commission, 1997.
3. Terpstra OT, van-Blankstein M, Dees J, Eilers GA. Abnormal patterns of cell proliferation in the entire colonie mucosa of patients with colon adenoma or cancer. Gastroenterology 1987; 92: 704-8.
4. Jass JR, Ajikora Y, Radojkovic M et al. Failure to detect colonie mucosal hyperproliferation in mutation positive members of a family with hereditary non-polyposis colorectal cancer. Histopatli. 1997;30:201-7.
5. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
6. Papadopoulos N, Nicolaides NC, Wei Y-F et al. Mutation of a miitL homolog in hereditary colon cancer. Science 1994; 263: 1625-9.
7. Fishel R, Lescoe MK, Rao MRS et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75: 1027-38.
8. Leach FS, Nicolaides NC, Papadopoulos N et al. Mutation of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993; 75: 1215-25.
9. Olschwang S, Hamelin R, Laurent-Puig P et al. Alternative genetic pathways in colorectal carcinogenesis. Proc. Natl Acad. Sei. USA 1997; 94: 12122-7.
10. Hickman JA. Apoptosis and chemotherapy resistance. Eur. J. Cancer 1996; 32A: 921-6.
11. Podack ER. Functional significance of two cytolytic pathways of cytotoxic T lymphocytes. J. Lenk. Biol. 1995; 57: 548-52.
12. Kerr JFR, Winterford CM, Harmon BV. Apoptosis: Its significance in cancer and cancer therapy. Cancer 1994; 73: 2013-26.
13. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972; 26: 239-57.
14. Baker SJ, Reddy EP. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 1996; 12: 1-9.
15. Ijiri K, Pötten CS. Response of intestinal cells of differing topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation. Br. J. Cancer 1983; 47: 175-85.
16. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc. Natl Acad. Sei. USA 1996; 93: 2239-44.
17. Kyprianou N, English HF, Isaacs JT. Activation of a Ca2+Mg2t-dependent endonuclease as an early event in castrationinduced prostatic cell death. Prostate 1988; 13: 103-17.
18. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555-6-
19. Bortner CD, Oldenburg NBE, Cidlowski JA. The role of DNA fragmentation in apoptosis. Trends Cell Biol. 1995; 5: 21-6.
20. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation./ Cell Biol. 1992; 119:493-501.
21. Arends MJ, Morris RG, Wyllie AH. Apoptosis. The role of the endonuclease. Am. J. Pathol. 1990; 136: 593-608.
22. Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J. 1995; 9: 219-28.
23. Eischen CM, Dick CJ, Leibson PJ. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J. Immunol. 1994; 153: 1947-54.
24. Kumar S, Harvey NL. Role of multiple cellular proteases in the execution of programmed cell death. FEBS Lett. 1995; 375: 169-73.
25. Patel T, Gores GJ, Kaufmann SH. The role of proteases during apoptosis. FASEB J. 1996; 10: 587-97.
26. Zamzami N, Marchetti P, Castedo M et al. Sequential reduction of mitochondria! transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 1995; 182: 367-77.
27. Kolesnick RN, Haimovitz-Friedman A, Fuks Z. The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem. CcllBiol 1994; 72: 471-4.
28. Whyte M. ICE/CED-3 proteases in apoptosis. Trends Cell Biol. 1996; 6: 245-8.
29. Alnemri ES, Livingston DJ, Nicholson DW et al. Human ICE/CED-3 protease nomenclature. Cell 1996; 87: 171.
30. Lu Q-L, Poulsom R, Wong L, Hanby AM. Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J. Pathol. 1993:169:431-7.
31. Pötten CS. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metastasis Rev. 1992; 11: 179-95.
32. Cormack DH. Essential Histology. Philadelphia: JB Lippincott Company, 1993.
33. Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: The importance of apoptosis. J. Cell Sei. 1994; 107: 3569-77.
34. Strater J, Koretz K, Gunthert AR, Moller P. In situ detection of enterocytic apoptosis in normal colonie mucosa and in familial adenomatous polyposis. Cut 1995; 37: 819-25.
35. Strater J, Wedding U, Barth TFE, Koretz K, Elsing C, Moller P. Rapid onset of apoptosis in vitro follows disruption of β1-integrin/matrix interactions in human colonie crypt cells. Gastroenterology 1996; 110: 1776-84.
36. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 1994; 124: 619-26.
37. Hague A, Hicks DJ, Bracey TS, Paraskeva C. Cell-cell contact and specific cytokines inhibit apoptosis of colonie epithelial cells: Growth factors protect against c-/;ryc-independent apoptosis. Br. J. Cancer 1997; 75: 960-8.
38. Raff MC. Social controls on cell survival and cell death. Nature 1992; 356: 397-400.
39. Bedi A, Pasricha PJ, Akhtar AJ et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res. 1995; 55: 1811-16.
40. Agrez MV. Cell adhesion molecules and colon cancer. Anst. N.Z. J.Surg. 1996:66:791-8.
41. Vogelstein B, Fearon ER, Hamilton SR el al. Genetic alterations during colorectal-tumor development. -N. Eng!. J. Med. 1988;319:525-32.
42. Rubinfeld B, Souza B, Albert I et al. Association of the APC gene product with -catenin. Science 1993; 262: 1731-4.
43. Su L-K, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993; 262: 1734-7.
44. Morin PJ, Vogelstein B, Kinzler KW. Apoptosis and APC in colorectal tumorigenesis. Proc. Natl Acad. Sei. USA 1996; 93: 7950-4.
45. McDonnell TJ. Cell division versus cell death: A functional model of multistep neoplasia. Mol. Carcinogen. 1993; 8: 209-13.
46. Charriaut-Marlangue C, Ben-Ari Y. A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport 1995; 7: 61-4.
47. Ichimura E, Fukuda T, Oyama T et al Formalin fixation by boiling: Is it suitable for the TUNEL staining? Pathol. Int. 1995:45:971-2.
48. Lucassen PJ, Chung WCJ, Vermeulen JP, Van Lookeren Campagne M, Hein Van Dierendonck J, Swaab DF. Microwaveenhanced i/i situ end-labeling of fragmented DNA. Parametric studies in relation to postmortem delay and fixation of rat and human brain. J. Histochem. Cytochem. 1995; 43: 1163-71.
49. Davison FD, Groves M, Scaravilli F. The effects of formalin
50. fixation on the detection of apoptosis in human brain by in situ end-labelling of DNA. Histochem. J. 1995; 27: 983-8.
51. Grasl-Kraupp B, Ruttkay-Nedccky B, Koudelka H, Bukowska K, Bursch V, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note. Hepatol. 1995; 21: 1465-8.
52. Baretton GB, Diebold J, Christoforis G et al. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Cancer 1996; 77: 255-64.
53. Moss SF, Scholes JV, Holt PR. Abnormalities of epithelial apoptosis in multistep colorectal neoplasia demonstrated by terminal deoxyuridine nick end labeling. Dig. Dis. Sei. 1996; 41: 2238-447.
54. Tatebe S, Ishida M, Kasagi N, Tsujitani S, Kaibara N, Ito H. Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: Analysis by terminal-deoxynucleotidyl-transferase-mediateddUTP-biotin nick end labeling. Int. J. Cancer 1996; 65: 173-7.
55. Hawkins N, Lees J, Margrave R, O'ConnorT, Meagher A, Ward R. Pathological and genetic correlates of apoptosis in the progression of colorectal neoplasia. Tumor Biol. 1997; 18: 146-56.
56. Ikenaga M, Takano Y, Saegusa M et al. Apoptosis of colon cancers assessed by in situ DNA nick end-labeling method. Pathollnt. 1996; 46: 33-7.
57. Koike M. Significance of spontaneous apoptosis during colorectal tumorigenesis. J. Surg. Oncol. 1996; 62: 97-108.
58. Pötten CS. What is an apoptotic index measuring? A commentary. Br. J. Cancer 1996; 74: 1743-8.
59. Takano Y, Saegusa M, Ikenaga M, Mitomi H, Okayasu I. Apoptosis of colon cancer: Comparison with Ki-67 proliferative activity and expression of p53. J. Cancer Res. Clin. Oncol. 1996; 122: 166-70.
60. Arai T, Kino I. Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas. J. Palhol. 1995; 176: 37-44.
61. Nakamura T, Sakai T, Nariya S. Cell death in colorectal polyps as evaluated by in situ 3'-tailing reaction and its relationship to BCL-2 expression. Pathol. Int. 1995; 45: 721-8.
62. Lane DP. p53, guardian of the genome. Nature 1995; 376: 37-43.
63. Lane DP, Lu X, Hupp T, Hall PA. The role of the p53 protein in the apoptotic response. Phil. Trans. R. Soc. Land. B 1994; 345: 277-80.
64. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. P53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 993n- 362: 847-9.
65. Strasser A, Harris AW, Jacks T, Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 1994; 79: 329-39.
66. Arita D, Kambe M, Ishioka C, Kanamaru R. Induction of p53independent apoptosis associated with G2M arrest following DNA damage in human colon cancer cell lines. Jpn. J. Cancer Res. 1997; 88: 39-43.
67. Arai T, Kida Y, Harmon BV, Gobe GC. Comparative alterations in p53 expression and apoptosis in the irradiated rat small and large intestine. Br. J. Cancer 1996; 74: 406-12.
68. Merritt AJ, Potten CS, Watson AJM et al. Differential expression of bcl-2 in intestinal epithelia. J. Cell Set. 1995; 108: 2261-71.
69. Potten CS, Li YQ, O'Connor PJ, Winton DJ. A possible explanation for the differential cancer incidence in the intestine, based on distribution of the cytotoxic effects of carcinogens in the murine large bowel. Carcinogen 1992; 13: 2305-12.
70. Howe GR, Benito E, Castelleto R et al. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J. Natl Cancer Inst. 1992; 84: 1887-96.
71. Roediger WEW. The role of anaerobic bacteria in the metabolic welfare of the colonie mucosa in man. Gut 1980; 21: 793-8.
72. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, Paraskeva C. Sodium butyrate induces apoptosis in human colonie tumour cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer. ///J. J. Cancer 1993; 55: 498-505.
73. Hague A; Elder DJE, Hicks DJ, Paraskeva C. Apoptosis in colorectal tumour cells: Induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int. J. Cancer 1995; 60: 400-6.
74. Valazquez OC, Lederer HM, Rombeau JL. Butyrate and the colonocyte: Implications for neoplasia. Dig. Dis. Sei. 1996; 41: 727-39.
75. Cheah PY. Hypotheses for the etiology of colorectal cancer: An overview. Nutr. Cancer 1990; 14: 5-13.
76. ReddyBS. Diet and excretion of bile acids. Cancer Res. 1981; 41: 3766-8.
77. Kandell RL, Bernstein C. Bile salt/acid induction of DNA damage in bacterial and mammalian cells: Implications for colon cancer. Nutr. Cancer 1991; 16: 227-38.
78. Payne CM, Bernstein H, Bernstein C, Garewal H. Role of apoptosis in biology and pathology: Resistance to apoptosis in colon carcinogenesis. Ultrastruct. Palhol. 1995; 19: 221-448.
79. Garewal H, Bernstein H, Bernstein C, Sampliner R, Payne C. Reduced bile acid-induced apoptosis in 'normal' colorectal mucosa: A potential biological marker for cancer risk. Cancer Res. 1996; 56: 1480-3.
80. Zheng Z-Y, Bernstein H, Bernstein C, Payne CM, Martinez JD, Gerner EW. Bile acid activation of the gadd!53 promoter and of p53-independent apoptosis: relevance to colon cancer. Cell Death Diff. 1996; 3: 407-14.
81. Baker SJ, Fearon ER, Nigro JM et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989:244:217-21.
82. Scott N, Martin I, Jack AS, Dixon MF, Quirk P. Genes mediating programmed cell death: An immunohistochemical study of bcI-2, c-myc and p53 expression in colorectal neoplasia. J. Clin. Palhol. Mol. Palhol. 1996; 49: M151-8.
83. Mosnier J-F, Perret AG, Vindimian M et al. An immunohistochemical study of the simultaneous expression of bcI-2 and p53 oncoproteins in epithelial tumors of the colon and rectum. Arch. Pathol. Lab. Med. 1996; 120: 654-9.
84. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 1995; 55: 237-41.
85. Meuller J, Meuller E, Hoepner I et al. Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: A comparative immunohistochemical study. J. Pathol. 1996; 180: 259-65.
86. Rodrigues NR, Rowan A, Smith MEF et al. P53 mutations in colorectal cancer. Proc. Natl Acad. Sei. USA 1990; 87: 7555-9.
87. Kobayashi M, Watanabe H, Ajioka Y, Yoshida M, Hitomi J, Asakura H. Correlation of p53 protein expression with apoptotic incidence in colorectal neoplasia. Virchows Arch. 1995; 427: 27-32.
88. Bosari S, Moneghini L, Graziani D et al. Bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas. Hum. Pathol. 1995; 26: 534-40.
89. Flohil CC, Janssen PA, Bosman FT. Expression of Bcl-2 protein in hyperplastic polyps, adenomas and carcinomas of the colon. J. Pathol. 1996; 178: 393-7.
90. Bronner MP, Culin C, Reed JC, Furth EE. The bcl-2 protooncogene and the gastrointestinal epithelial tumor progression model. Am. J. Pathol. 1995; 146: 20-6.
91. Ayhan A, Yasui W, Yokozaki H, Seto M, Ueda R, Tahara E. Loss of heterozygosity at the bcl-2 gene locus and expression of bcl-2 in human gastric and colorectal carcinomas. Jpn J. Cancer Res. 1994; 85: 584-91.
92. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerises in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 1993; 74: 609-19.
93. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293-9.
94. Rampino N, Yamamoto H, lonov Y et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1994; 275: 967-9.
95. Kim H, Jen J, Vogelstein B et al. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am. J. Pathol. 1994; 145: 148-56.
96. Lowe SW, Ruley HE, Jacks T, Housman DE. P53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993b; 74: 957-67.
97. Clarke AR, Purdie CA, Harrison DJ et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993:362:849-52.
98. Lowe SW, Bodis S, McCIatchey A et al. P53 status and the efficacy of cancer therapy in vivo. Science 1994; 266: 807-10.